HSD14 Characteristics of US Commercially Insured Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1237
https://www.valueinhealthjournal.com/article/S1098-3015(24)01352-4/fulltext
Section Title :
Section Order :
10638
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01352-4&doi=10.1016/j.jval.2024.03.1237